Archemix Corp. is a drug discovery and development company based in Cambridge, Mass. Founded in May 2001, the company's mission is to discover aptamer-based therapeutics and to develop RiboReporter„-based technologies to improve the process of drug discovery and development. Both of these technologies derive from Archemix's selected nucleic acid technology. |